![Fadi Haddad: Ghayas Issa presenting the results of AUGMENT-101](https://oncodaily.com/pub/uploads/2024/06/ghayas_issa.jpg.resize.810.1150.high_-e1718946893134.jpg)
Photo of Ghayas Issa from faculty.mdanderson.org
Jun 19, 2024, 22:24
Fadi Haddad: Ghayas Issa presenting the results of AUGMENT-101
Fadi Haddad, Assistant Professor of the Leukemia Department at MD Anderson Cancer Center, Houston, shared a post on X/Twitter:
“Ghayas Issa from MD Anderson Cancer Center presenting the results of AUGMENT-101:
- N=57 evaluable for efficacy
- KMT2Ar leukemias
- Heavily pretreated patients, 46% with >3 prior lines
- CR/CRh=23%, mOS=8 months
- No discontinuation due to DS”
Source: Fadi Haddad/X